About Epineuron
Epineuron is a company based in Hamilton (Canada) founded in 2016 by Mike Willand and Sergio Aguirre. Epineuron offers products and services including PeriPulseâ„¢ Nerve Stimulation System. Epineuron operates in a competitive market with competitors including Avation, Tulavi Nerve Therapeutics, BioCircuit, RxFunction and Monarch Bioimplants, among others.
- Headquarter Hamilton, Canada
- Founders Mike Willand, Sergio Aguirre
- SectorsHealthcare
- Email••••••••
- Website epineurontech.com
- Social LinkedIn X Instagram
- Legal Name Epineuron Technologies Inc.
- InvestorsOntario Centre of Innovation
& 1 more
Products & Services of Epineuron
Epineuron offers a comprehensive portfolio of products and services, including PeriPulse™ Nerve Stimulation System.
Delivers electrical stimulation to regenerate damaged nerves.
Funding Insights of Epineuron
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of Epineuron with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2020 | – | Seed | – | Ontario Brain Institute, Ontario Centre of Innovation | – |
2 investors in total: 2 institutional.
Investors in Epineuron
Epineuron has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ontario Centre of Innovation and Ontario Brain Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Brain research and care innovation is driven in Ontario. | – | braininstitute.ca | Toronto, Canada | |
Research and development services are delivered to an innovation community. | 1987 | oc-innovation.ca | Toronto, Canada |
Investor details for Epineuron
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Epineuron
2 people are tracked at Epineuron (2 in leadership).
| Name | Role | Group |
|---|---|---|
Mike Willand | Co-Founder | Leadership |
Sergio Aguirre | Co-Founder & CEO | Leadership |
Complete people profiles for Epineuron
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Epineuron
2 dated milestones of Epineuron across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Epineuron is founded.
- Funding First funding round.
Competitors of Epineuron
Epineuron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avation, Tulavi Nerve Therapeutics, BioCircuit, RxFunction and Monarch Bioimplants, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avation.com | 1999 | Columbus, United States | $34.92M | – | Wearable tibial nerve stimulation device treats overactive bladder symptoms. | |
| tulavi.com | 2020 | Mountain View, United States | $4M | – | Therapeutic devices for neurally mediated diseases are developed. | |
| biocircuit.com | 2016 | Atlanta, United States | $13.65M | – | Non-invasive electrophysiology devices are developed to monitor peripheral nerves. | |
| rxfunction.com | 2010 | Minneapolis, United States | $39.95M | 30 | Wearable prostheses for sensory peripheral neuropathy patients are developed. | |
| monarchbioimplants.com | 2016 | Root, Switzerland | $24.93M | – | Developer of bioimplant for peripheral nerve repair | |
| micro-leads.com | 2014 | Boston, United States | – | – | Micro-cuff electrodes and wireless pulse generators for neuromodulation are developed. | |
| renerva.com | 2017 | Pittsburgh, United States | $1.28M | – | Implants for peripheral nerve repair are developed for injury treatment. | |
| photothera.com | 1997 | Carlsbad, United States | $80.5M | – | Provides advanced laser therapy solutions for healthcare applications. |
Detailed competitors of Epineuron
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Epineuron
The website of Epineuron (epineurontech.com) receives about 1.3K visits a month.
- Monthly visits1.3K
Latest news on Epineuron
Complete news archive for Epineuron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Epineuron
10 companies that operate in the same segment as Epineuron (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Epineuron
Epineuron was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Epineuron is headquartered in Hamilton, Canada. It is registered at Hamilton, Ontario, Canada.
Sergio Aguirre is the current CEO of Epineuron. They have also founded this company.
Epineuron Technologies was founded in 2016 in Hamilton, Canada, within the medical devices sector. Peripheral nerve injuries such as transection, crush, compression, traction, and ischemia are treated through specialized devices. Electrical stimulation of nerves is applied to support natural biochemical processes for healing and repair, addressing resulting physical disabilities. Operations focus on healthcare applications in nerve regeneration.
Epineuron's top competitors include Avation, Tulavi Nerve Therapeutics and RxFunction.
Epineuron offers PeriPulseâ„¢ Nerve Stimulation System.
Epineuron has 2 investors. Key investors include Ontario Centre of Innovation, and Ontario Brain Institute.
Epineuron operates through Epineuron Technologies Inc..